COVID-19 Immunity And An Update on ARB/ACEIs
Time has Come to Eliminate SARS-COV-2
More lectures on drbeen.com
Looking to support my educational work? Donate here:
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
CD38 Cells White Cells Marker – (T Cells, B Cells, and Natural Killer Cells)
Interferon Gamma
